Rituximab in thrombotic microangiopathy [4]

British Journal of Haematology

Volumn 139, Issue 1, 2007, Pages 166-

  Castagna, Luca ^a   Todisco, Elisabetta ^a   Sarina, Barbara ^a   Santoro, Armando ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

ADAMTS 13; Rituximab; Thrombotic microangiopathy

Indexed keywords

CYCLOSPORIN; RITUXIMAB; STEROID; TACROLIMUS; VON WILLEBRAND FACTOR CLEAVING PROTEINASE; IMMUNOLOGIC FACTOR; MONOCLONAL ANTIBODY;

DRUG EFFICACY; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LETTER; PLASMAPHERESIS; PRIORITY JOURNAL; RISK FACTOR; THROMBOTIC THROMBOCYTOPENIC PURPURA; ADULT; FEMALE; MALE; MICROCIRCULATION; NOTE; POSTOPERATIVE COMPLICATION; THROMBOSIS; UNNECESSARY PROCEDURE;

ADULT; ANTIBODIES, MONOCLONAL; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOLOGIC FACTORS; MALE; MICROCIRCULATION; PLASMA EXCHANGE; POSTOPERATIVE COMPLICATIONS; THROMBOSIS; UNNECESSARY PROCEDURES;

EID: 34548583548     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2007.06767.x     Document Type: Letter

References (3)

1. Au, W.Y., Ma, E.S., Lee, T.L., Ha, S.Y., Fung, A.T., Lie, A.K. Kwong, Y.L. (2007) Successful treatment of thrombotic microangiopathy after haematopoietic stem cell transplantation with rituximab. British Journal of Haematology, 137, 475 478.
2. Peyvandi, F., Siboni, S.M., Lambertenghi Deliliers, D., Lavoretano, S., De Fazio, N., Moroni, B., Lambertenghi Deliliers, G. Mannuccio Mannucci, P. (2006) Prospective study on the behaviour of the metalloprotease ADAMTS13 and of von Willebrand factor after bone marrow transplantation. British Journal of Haematology, 134, 187 195.
3. Zeigler, Z.R., Shadduck, R.K., Nemunaitis, J., Andrews, D.F. Rosenfeld, C.S. (1995) Bone marrow transplant-associated thrombotic microangiopathy: a case series. Bone Marrow Transplantation, 15, 247 253.